I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Commercially available 5-bromo-2-fluoropyridine was treated with LDA at -78°C to give the lithiated species. Fluoropyridine-based bromoacetamide reagent has been prepared and used in prosthetic group introduction for the labeling of oligonucleotides.
Bryan W. Stroup,; Paul V. Szklennik,; Cornelia J. Forster,; Michael H. Serrano-Wu.Chemoselective Amination of 5-Bromo-2-chloro-3-fluoropyridine. Org. Lett.,. 2007, 9(10),2039-2042.
Bertrand Kuhnast,; Béatrice de Bruin,; Françoise Hinnen,; Bertrand Tavitia,; Frédéric Dollé .Design and Synthesis of a New [18F]Fluoropyridine-Based Haloacetamide Reagent for the Labeling of Oligonucleotides:? 2-Bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide . Bioconjugate Chem.,. 2004, 15 (3), 617-627.
Gefahrenhinweise (EU): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.